3
Announcements
Trials
Browse
Landscape
Phase
Phase 3
2
Phase 2
2
Phase EARLY_PHASE1
1
Status
Recruiting
1
Completed
1
Sponsor Class
INDUSTRY
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
2
Conditions
Neoplasms
2
Lung Neoplasms
2
Colorectal Neoplasms
2
Carcinoma, Non-Small-Cell Lung
2
KRAS p, G12c Mutated /Advanced Metastatic NSCLC
1
Interventions
Fluorouracil
131
Leucovorin
127
Oxaliplatin
93
Bevacizumab
86
Irinotecan
74
Capecitabine
63
Cetuximab
47
Folfox protocol
32
Panitumumab
18
regorafenib
16
trifluridine tipiracil drug combination
15
Drug Therapy
14
Chemotherapy, Adjuvant
13
IFL protocol
10
Floxuridine
10
Radiotherapy
9
Tegafur
7
Neoadjuvant Therapy
7
Levoleucovorin
7
Laparoscopy
7
Aspirin
7
pembrolizumab
6
atezolizumab
6
Trifluridine
6
Celecoxib
6
XELOX
5
Mitomycin
5
Colonoscopy
5
tipiracil
4
sintilimab
4
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 3
×
Colorectal Neoplasms
×
sotorasib
×
Clear all
NCT05198934
2026-04-27
CodeBreak300
Amgen
Phase 3
Completed
160 enrolled
1 FDA
NCT06252649
2026-04-24
CodeBreaK 301
Amgen
Phase 3
Recruiting
450 enrolled